Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hygea VCT Increases NAV Per Share, Changes RBS Overdraft To Loan

Thu, 03rd May 2018 13:43

LONDON (Alliance News) - Hygea VCT PLC said on Thursday its net present value per share increased in the recent quarter.

At March 31, Hygea's NAV per share was 64.4p, up from 63.8p at the end of 2017.

The medical technology investor said its holding in Scancell Holdings PLC represents one third of its portfolio. Scancell's share price of 13.5p at the time of NAV calculation represented a 1.0p increase from December.

Scancell conducted a placing in April to raise GBP8.9 million and, as a result, Hygea's share was further diluted to 13.1 million shares, 3.5% of Scancell's share capital. Scancell shares were quoted at 11.97p on AIM Thursday.

Hygea sold 100,000 shares in Scancell during the quarter at 18p per share for liquidity management purposes.

The company said it has used GBP166,822 of its GBP200,000 overdraft facility. The overdraft facility was then converted to a formal loan of GBP200,000 following ring-fencing changes at the Royal Bank of Scotland, the loan is due to be repaid by September 30.

Hygea confirmed that a prospectus to raise up to GBP10 million via the issue of new B shares to be managed by Seneca Partners Ltd is expected to be issued "shortly".

Shares in Hygea were untraded Thursday but last closed at 50.20 pence each.

More News
25 Apr 2019 11:19

Scancell gets go-ahead for UK second phase trials of 'SCIB1'

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.

Read more
8 Apr 2019 11:34

Scancell Holdings expands IP protection with Japanese patent

(Sharecast News) - Scancell Holdings on Monday won a Japanese patent for its Moditope immunotherapy platform, which stimulates the production of cells that overcome the immune suppression induced by tumours.

Read more
8 Apr 2019 11:27

Scancell Gets Japan Patent Protecting Moditope Immunotherapy Platform

LONDON (Alliance News) - Scancell Holdings PLC on Monday said the Japanese Patent Office has granted a patent providing protection for its Moditope immunotherapy platform.The cancer said T

Read more
20 Mar 2019 13:38

Scancell Holdings Gets Further Patent Protection In US And Europe

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC has received a new patent for its Modi-1 drug candidate in the US, it said on Wednesday.The patent, granted by the US in in

Read more
31 Jan 2019 13:59

Loss Widens As Scancell Continues Moditope Cancer Vaccine Development

LONDON (Alliance News) - Scancell Holdings PLC on Thursday said its loss widened in the first half of its year on mounting administrative expenses as its development of Moditope in Scancell were a

Read more
31 Jan 2019 09:48

Scancell shares slip as losses widen in first half

(Sharecast News) - Cancer immunotherapies developer Scancell Holdings issued its interim results for the six months ended 31 October on Thursday, reporting a loss of £3.24m, widening from £2.02m year-on-year.

Read more
23 Jan 2019 11:20

Scancell loses out on Cancer Research UK grant

(Sharecast News) - Immunotherapies developer Scancell has seen Cancer Research UK pass on its submission into the Grand Challenge research initiative.

Read more
23 Jan 2019 10:41

WINNERS & LOSERS SUMMARY: Metro Bank Slumps 29% On Annual Profit Miss

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 1.9%. The airline was extending gains a

Read more
23 Jan 2019 10:18

Scancell Cancer Vaccine Project Misses Out On Cancer Research UK Grant

LONDON (Alliance News) - Scancell Holdings PLC said Wednesday its Project Blueprint proposal was not selected for the Cancer Research UK Grand Challenge grant.Shares in Scancell were down -

Read more
21 Jan 2019 12:58

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Read more
21 Jan 2019 12:30

Scancell appoints new heads of research and manufacturing

(Sharecast News) - Immunotherapy developer Scancell Holdings announced the appointment of Dr Samantha Paston as its head of research, and Dr Adrian Parry as its head of manufacturing, on Monday.

Read more
30 Oct 2018 16:33

Scancell Holdings Reports Tumour Rejection Data In Cancer Vaccine

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that data from its second vaccine from its Moditope platform, Modi-2, showed T-cell response, tumour rejection and increased survival in

Read more
30 Oct 2018 14:36

Scancell pleased with progress on 'Moditope' vaccines

(Sharecast News) - Novel immunotherapies developer Scancell Holdings updated the market on the development of its second vaccine from its proprietary 'Moditope' platform, Modi-2, on Tuesday, reporting that pre-clinical data demonstrated that homocitrullinated peptides induced highly potent T-cell responses, tumour rejection and increased survival in murine models.

Read more
24 Oct 2018 12:28

Oxford Technology VCTs Mostly Report Drop In Net Asset Value

LONDON (Alliance News) - The Oxford Technology-managed venture capital trusts reported interim results on Wednesday, with all but one see a drop in net asset value.Oxford Technology Venture

Read more
24 Oct 2018 10:43

WINNERS & LOSERS SUMMARY: Metro Bank Down Amid Mortgage Competition

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 0.9%. The bank reported a rise in third by

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.